Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in Illinois

If you’re a psychiatrist or psychiatric nurse practitioner thinking about telepsychiatry — or already practicing remotely — you’re probably asking: Can I actually prescribe ADHD meds over video? What about controlled substances? Do I need a collaborating physician in this state?

Fair questions. The rules around prescribing psychiatric medications via telehealth are finally stabilizing after years of pandemic-era chaos, but they’re still a patchwork of federal waivers and state-specific quirks that can trip you up if you’re not careful.

Here’s the reality: Telepsychiatry prescribing is fully viable in 2026 — psychiatrists can manage everything from depression to ADHD to anxiety disorders remotely, including controlled substances like stimulants and benzodiazepines. But the details matter, especially if you’re a PMHNP navigating scope-of-practice restrictions or a psychiatrist practicing across multiple state lines.

This guide breaks down exactly what you can prescribe via telehealth, how state laws differ (especially for nurse practitioners), what reimbursement looks like, and where the regulatory landmines are hiding.

The Federal Landscape: DEA Waivers and the Ryan Haight Act

Let’s start with the elephant in the room: prescribing controlled substances via telehealth.

Historically, the Ryan Haight Act required an in-person exam before any provider could prescribe Schedule II–V controlled substances. That made remote ADHD treatment or anxiety management nearly impossible unless you saw patients face-to-face first.

Then COVID hit, and the DEA waived that requirement under public health emergency powers. As of early 2026, those waivers remain in effect through December 31, 2025 — meaning you can still prescribe stimulants, benzodiazepines, buprenorphine, and other controlled meds to new patients via video visit without an initial in-person exam.

What this means practically:

• A psychiatrist in Texas can start a new ADHD patient on Adderall after a 60-minute video evaluation
• A PMHNP in New York (with appropriate authority) can prescribe Xanax for panic disorder via telehealth
• A provider in California can initiate Suboxone for opioid use disorder remotely

The catch: The DEA has proposed new permanent rules that could require some in-person contact — either an initial visit, or periodic check-ins, or limits on prescription duration (like a 30-day supply cap for initial scripts). These rules have been delayed multiple times, but providers should expect some version to land by late 2024 or early 2025.

Bottom line for now: You can prescribe psychiatric controlled substances via telehealth nationwide under the current federal waiver. Stay alert for DEA announcements, but don’t let uncertainty paralyze you — the telehealth flexibilities have proven so valuable for mental health access that most expect permanent allowances (with reasonable guardrails) rather than a return to the strict in-person mandate.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

State-by-State Reality Check: It’s Complicated

Federal law sets the floor, but states can add their own restrictions — and in psychiatry, those restrictions vary wildly.

The Three Models of NP Prescribing Authority

If you’re a psychiatrist, you have full independent prescribing authority in all 50 states. No supervision, no collaboration agreements, no scope restrictions beyond standard medical practice. Your only requirements are state licensure and DEA registration.

PMHNPs face a different reality. States fall into three categories:

1. Full Practice Authority (FPA) States (~34 states as of 2025)

In these states, experienced PMHNPs can practice and prescribe independently — no physician oversight required. You can open your own practice, evaluate patients, diagnose, and prescribe controlled substances under your own DEA number.

Examples: Washington, Oregon, Arizona, New Mexico, Colorado, Minnesota, Massachusetts (since 2021), Kansas (2022), Indiana (2023), Louisiana (2024).

What this means: A PMHNP in Colorado can do everything a psychiatrist does in terms of medication management. They bill under their own NPI, carry their own DEA license, and don’t need a psychiatrist to co-sign charts or approve prescriptions.

2. Reduced Practice States (pathway to independence)

These states require initial physician collaboration but allow independence after a supervised transition period — usually 2–4 years.

New York: PMHNPs need a written collaborative agreement with a physician for their first 3,600 hours (~2 years full-time). After that, they practice independently with just an informal ‘collaborative relationship’ for consultation — no ongoing supervision or chart review required.

Illinois: Requires 4,000 hours of collaboration plus 250 hours of continuing education before a PMHNP can apply for Full Practice Authority licensure. Until then, all prescribing is under physician delegation (the collaborating physician’s name must appear on prescriptions).

California: Transitioning to FPA via a two-tier system. As of 2023, NPs with 3+ years experience can practice in group settings without direct supervision (‘103 NP’ certification). Starting January 2026, they can apply for full independence (‘104 NP’) to practice solo. New grads still need physician-supervised protocols for their first three years.

3. Restricted Practice States (ongoing supervision required)

These states require permanent physician collaboration or supervision — no matter how experienced you are.

Texas: All PMHNPs must have a Prescriptive Authority Agreement with a Texas-licensed physician to prescribe anything. The agreement must include regular meetings (monthly for the first 3 years, quarterly after that) and chart review protocols. Texas also limits each physician to supervising no more than 7 NPs/PAs simultaneously.

Extra twist: Texas NPs generally cannot prescribe Schedule II controlled substances in outpatient settings (with very narrow exceptions for terminal illness). That means a Texas PMHNP typically can’t independently manage ADHD with stimulants — the collaborating physician often writes those prescriptions.

Florida: Created an ‘autonomous APRN’ category for family/internal medicine NPs, but psychiatric NPs were excluded. PMHNPs still need physician supervision. However, Florida law explicitly allows ‘psychiatric nurses’ (PMHNPs with 2+ years experience under a psychiatrist) to prescribe psychotropic controlled substances in collaboration with a psychiatrist — and exempts them from the 7-day Schedule II supply limit that applies to other NPs.

Pennsylvania: Requires a collaborative agreement indefinitely (no pathway to independence yet, though legislation has been proposed). The agreement must specify prescribing authority, and the physician must review a portion of charts regularly. PA NPs can prescribe Schedule II meds if delegated, but with a 30-day supply limit and 24-hour physician notification requirement.

The Collaborative Agreement Reality

If you’re a PMHNP in a restricted or reduced-practice state, the quality of your collaborative agreement matters.

What these agreements typically include:

• Defined scope: What conditions you can treat, what medications you can prescribe (some agreements exclude certain drug classes or age groups)
• Chart review requirements: Monthly or quarterly review of a percentage of your patient charts
• Availability requirements: How quickly the collaborating physician must be reachable for consultation
• Meeting frequency: Regular face-to-face or video meetings to discuss cases and review protocols
• Prescribing limits: Some agreements restrict Schedule II prescribing or require physician approval for certain medications

The pain points:

• Finding a collaborator can be challenging, especially in underserved areas. Many psychiatrists charge $1,000–$3,000+/month to collaborate, cutting into your income.
• State restrictions on who can collaborate: Florida requires the collaborating physician to be a psychiatrist for psych NP prescribing authority. Pennsylvania requires the physician to have relevant specialty experience.
• Multi-state complications: If you’re licensed in multiple states to practice telehealth, you may need different collaborative agreements for each state — and they may have conflicting requirements.

For psychiatrists, these agreements can represent either an administrative burden (if you’re supervising NPs) or a business opportunity (some charge supervision fees or structure profit-sharing arrangements with NPs in their practice).

State Spotlight: Telehealth Prescribing Rules Where They Actually Matter

Let’s get specific about the priority states for telepsychiatry:

California: The Transition State

Psychiatrists: Full independent authority. Can prescribe via telehealth after a ‘good faith exam’ (video qualifies). No special restrictions on controlled substances under the federal waiver.

PMHNPs: In transition. New grads need physician-supervised ‘standardized procedures’ for their first 3 years. After 3 years, can become a ‘103 NP’ (independent practice in group settings). Starting 2026, can become a ‘104 NP’ (full solo practice independence).

Telehealth specifics: California law explicitly permits telehealth exams to satisfy the ‘appropriate prior examination’ requirement. Must check CURES (California’s prescription monitoring database) before prescribing Schedule II–IV. Strong telehealth parity — private insurers must cover and reimburse at same rates as in-person.

Market reality: California has 11+ million residents in mental health professional shortage areas. High demand, but also high cost of living and competitive provider market in urban areas. Rural and Central Valley regions desperately need providers.

Texas: The Strict Supervision State

Psychiatrists: Independent. Can prescribe via telehealth for mental health conditions, including controlled substances (under federal waiver). Texas prohibits teleprescribing controlled substances for chronic pain — must see those patients in-person — but psychiatric treatment is exempt.

PMHNPs: Must have Prescriptive Authority Agreement with a physician. Generally cannot prescribe Schedule II controlled substances in outpatient practice. Can prescribe Schedule III–V if delegated (includes most benzodiazepines, but not Adderall/Ritalin).

Telehealth specifics: Texas requires real-time audio-visual communication for valid telemedicine encounters. Must maintain same standard of care as in-person. Must check Texas PMP before prescribing controlled substances.

The collaboration hurdle: Texas limits physicians to supervising 7 NPs/PAs. In a state with massive mental health shortages (1 psychiatrist per 8,500+ residents), this creates bottlenecks for PMHNP practice expansion.

Market reality: Huge underserved population, especially in rural areas and border regions. High patient demand but restrictive NP rules mean PMHNPs often work for larger organizations that provide physician oversight.

Florida: The Psychiatric Exception State

Psychiatrists: Independent. Florida has one of the most permissive telehealth laws: explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (carved out from the chronic pain prohibition).

PMHNPs: Must practice under physician supervision. ‘Psychiatric nurses’ with 2+ years experience under a psychiatrist can prescribe psychotropic controlled substances (and are exempt from the 7-day Schedule II limit that applies to other NPs).

Telehealth specifics: FL statute 456.47 permits teleprescribing of controlled substances for mental disorders, inpatient care, hospice, and nursing homes — but prohibits it for chronic non-cancer pain. This makes Florida particularly friendly for tele-ADHD and anxiety treatment.

Market reality: Worst psychiatrist-to-population ratio in the nation (~1:9,000). Massive elderly population with high rates of anxiety and depression. Growing telehealth market but NP restrictions limit independent practice models.

New York: The Experience-Based Independence State

Psychiatrists: Independent. New York recently finalized regulations allowing controlled substance prescribing via telehealth in alignment with federal DEA waivers (removed prior state-level obstacles).

PMHNPs: Need collaborative agreement for first 3,600 hours. After that, can practice fully independently (just need an informal ‘collaborative relationship’ for consultation/referral — no supervision or chart review).

Telehealth specifics: NY requires e-prescribing for all controlled substances (no paper scripts). Must check I-STOP (NY’s PMP) before prescribing Schedule II–IV. Strong telehealth parity mandates for insurance coverage.

Medicare caveat: Starting 2025, Medicare patients receiving tele-mental health must have an in-person visit at least once every 6–12 months (Medicare billing requirement, not state law).

Market reality: High concentration of psychiatrists in NYC (1:2,900 residents statewide), but upstate and rural regions severely underserved. The 2022 law enabling NP independence has helped fill gaps in those areas.

Pennsylvania: The Stuck-in-Collaboration State

Psychiatrists: Independent. No special telehealth restrictions beyond federal law.

PMHNPs: Must maintain collaborative agreement indefinitely (no pathway to independence despite proposed legislation). Can prescribe Schedule II if delegated, but 30-day limit and must notify physician within 24 hours.

Telehealth specifics: PA Medicaid and major insurers cover telepsychiatry, though the state lacks comprehensive telehealth parity statute. Physicians must review portion of NP charts and meet at least twice yearly.

Market reality: Mid-level provider density (1:4,586 residents statewide). Rural central PA has significant shortages. High NP training capacity, but some leave for neighboring states with FPA (New York, Ohio, West Virginia recently went FPA).

Illinois: The Transition-to-Independence State

Psychiatrists: Independent. Illinois has strong telehealth parity (mandated equal reimbursement through 2027).

PMHNPs: Must complete 4,000 hours supervised practice + 250 CE hours, then can apply for Full Practice Authority. Until FPA granted, prescriptions must list collaborating physician’s name. With FPA, can prescribe Schedule II–V independently (must get mid-level controlled substance license).

Telehealth specifics: IL’s Telehealth Act requires private insurers to cover telehealth at parity for behavioral health. Can prescribe via telehealth under federal waivers. Must follow standard controlled substance protocols.

Unique note: Illinois allows licensed clinical psychologists with specialized training to prescribe limited mental health medications under psychiatrist supervision (addressing workforce gaps).

Market reality: ~291 additional practitioners needed to eliminate mental health shortage areas. High demand in rural southern Illinois and some urban underserved neighborhoods.

The Economics: What Medication Management Actually Pays

Let’s talk money. Understanding reimbursement is critical for practice sustainability — whether you’re evaluating a telehealth platform or planning your own practice.

Common Billing Codes

Initial psychiatric evaluation with medication management: CPT 90792 (~60 minutes)

• Medicare 2026: ~$173
• Typical private insurance: $200–$300+

Follow-up medication management visits:

• 99213 (15-minute straightforward med check): Medicare ~$95, private insurance $120–$150+
• 99214 (25-minute moderate complexity): Medicare ~$136, private insurance $150–$200+
• 99215 (40-minute high complexity): Medicare ~$192, private insurance $250+

Most routine psychiatric medication management visits are 15–20 minutes and billed as 99213 or 99214.

If you’re combining brief psychotherapy with medication management (e.g., 15 minutes of med check + 15 minutes of supportive therapy), you can add psychotherapy codes:

• 90833 (30-min add-on): +$80 Medicare
• 90836 (45-min add-on): +$110 Medicare

Medicare vs Private Insurance vs Medicaid

Medicare: National benchmark rates. Pays psychiatrists at 100% of fee schedule. Pays PMHNPs at 85% when billed under NP’s NPI (can’t use ‘incident-to’ billing for telehealth, so that’s the practical rate).

Private insurance: Typically pays 1.2–1.8x Medicare rates in most markets. Urban/high-cost areas often higher. Most major payers have telehealth parity for mental health (same payment as in-person).

Medicaid: Varies widely by state. Often 60–80% of Medicare rates, but some states have enhanced behavioral health rates. Many state Medicaids pay telehealth at parity with in-person.

Telehealth Parity: The Silver Lining of the Pandemic

Pre-pandemic, many insurers paid less for telehealth or didn’t cover it at all. That’s changed dramatically.

States with permanent telehealth parity laws (for mental health):

• California: AB 744 requires payment parity for contracts after 2021
• Illinois: SB 667 mandates equal reimbursement through 2027
• New York: Strong parity mandates in place
• Connecticut, Massachusetts, Georgia: Passed permanent parity laws 2022–2023

Federal: Medicare permanently covers tele-mental health services (with minor requirement for periodic in-person visits, currently paused). Also covers audio-only mental health visits for patients without video access — same rate as video/in-person.

What this means: A psychiatrist doing a 15-minute med check via video gets paid the same $95 (Medicare) or $120–$150 (private insurance) as if the patient sat in the office. Zero penalty for delivering care remotely.

The NP Reimbursement Gap

Even in states where PMHNPs have full prescribing authority, reimbursement can differ:

• Medicare: 85% of physician rate (psychiatrist gets $95 for 99213, PMHNP gets ~$81)
• Private insurance: Varies by contract — some pay NPs at same rate, others 85–90%, some require billing under supervising physician to get full rate
• Some states (Nevada, Maryland) have passed equal reimbursement laws requiring insurers pay NPs same as MDs for same service

For a practice, this creates interesting dynamics:

• If you’re employing both psychiatrists and PMHNPs, the revenue per visit may differ
• If you’re an NP in a reduced-practice state, billing ‘incident-to’ a physician (if allowed) can capture 100% reimbursement — but that only works in-office, not telehealth
• For direct-pay/cash practices, this is moot — you set your own rates

The Real Economics of Patient Acquisition

Here’s where provider marketing gets messy with inflated claims.

Reality check: Acquiring a qualified psychiatric patient through DIY marketing (SEO, Google Ads, directories) typically costs $200–$500+ per patient when you factor in:

• Agency/consultant fees ($2,000–$5,000/month for decent SEO/PPC)
• Ad spend testing and optimization (mental health keywords cost $15–$40+ per click on Google)
• Staff time to handle and qualify leads
• No-show rates from cold leads (30–50% for first appointments from ads)
• Months of SEO investment before meaningful results (6–12 months typical)
• Failed campaigns and wasted spend

Examples:

• SEO: Takes 6–12 months of consistent content creation, technical optimization, and backlink building before you rank for competitive terms like ‘psychiatrist near me’ or ‘ADHD treatment [city]’. Most solo providers don’t have the expertise or budget for this.
• Google Ads: Click costs for ‘online psychiatrist’ or ‘ADHD medication management’ run $20–$40+. Conversion rate from click to booked appointment is typically 3–8% (most clicks don’t convert). Realistic cost per booked patient: $200–$400+.
• Psychology Today/Zocdoc: Monthly directory fees ($30–$100/month) plus you’re competing with hundreds of other providers. Zocdoc charges per booking ($35–$100+ depending on specialty). Total monthly cost can hit $500–$1,500 for modest patient flow.

When DIY marketing works: If you have the budget ($3,000–$5,000/month minimum), expertise (or hire specialists), and patience (6+ months to see ROI), you can build a sustainable patient acquisition channel. Great for established practices looking to scale.

When it doesn’t: For providers starting out, ramping up telehealth hours, or testing a new market, the upfront investment and uncertainty make DIY marketing a risky bet.

The Klarity Health Model: Pay-Per-Appointment Simplicity

This is where platforms like Klarity Health change the economics.

Instead of:

• $3,000–$5,000/month in marketing spend (win or lose)
• Months of waiting for SEO results
• Wasted ad spend on clicks that don’t convert
• Staff time screening unqualified leads

You get:

• No upfront marketing costs — zero monthly subscriptions or ad budgets
• Pay only when you see patients — standard listing fee per new patient lead (similar to Zocdoc’s model but for qualified psychiatric patients)
• Pre-qualified patients already matched to your specialty and availability
• Built-in telehealth infrastructure (no separate platform fees)
• Both insurance and cash-pay patient flow (depending on your preference)
• You control your schedule — see 5 patients/week or 50, you only pay for actual appointments

The economics: Instead of gambling $4,000/month on marketing that might bring 8–15 patients (if you’re lucky and skilled), you pay a predictable per-patient fee only when someone books and shows up. That’s guaranteed ROI vs uncertain marketing spend.

Example math:

• Traditional: $4,000/month marketing → 12 new patients (if successful) = $333/patient acquisition cost
• Klarity model: Standard per-appointment fee (competitive with other patient acquisition costs) → 12 patients = you paid only for those 12, no wasted spend

The key difference: risk transfer. In DIY marketing, you bear all the risk of failed campaigns, seasonal dips, algorithm changes, and learning curves. With a pay-per-appointment platform, the platform handles patient acquisition — you just show up and treat patients.

Who this works for:

• Psychiatrists and PMHNPs starting telehealth practices (avoid $10K–$20K in upfront marketing investment)
• Providers expanding to new states (test markets without committing to local SEO/ads)
• Anyone who wants predictable patient flow without managing marketing vendors

Honest comparison: Once you’re at scale (50+ hours/week fully booked), DIY marketing can be more cost-effective if you’ve nailed your channels. But getting there takes 12–24 months and significant capital. For most providers, especially those building or scaling, a platform that removes acquisition risk entirely is the smart economic choice.

Compliance Essentials: How Not to Lose Your License

Telehealth prescribing isn’t just about knowing you can prescribe — it’s about doing it correctly to avoid regulatory trouble.

Documentation Standards

You must maintain the same standard of care as in-person practice. That means:

• Thorough history and mental status exam documented for initial evaluations
• Verification of patient identity (most platforms handle this, but confirm)
• Informed consent for telehealth including limitations, privacy risks, emergency protocols
• Documentation of technology used (video, audio-only, specific platform)
• Emergency backup plan if patient is in crisis and disconnects

Many state medical boards require documentation that:

• The patient’s location was verified (needed for licensure compliance and emergency services)
• Appropriate technology was used (e.g., HIPAA-compliant platform)
• Consent was obtained

For controlled substance prescribing, document:

• Rationale for medication choice
• Prescription Monitoring Program (PMP) check — mandatory in most states before prescribing Schedule II–IV
• Discussion of risks (addiction potential, side effects)
• Treatment agreement if applicable (some practices use these for stimulants)

Prescription Monitoring Programs (PMPs)

Almost every state requires checking the PMP before prescribing controlled substances. Requirements vary:

• California (CURES): Must check at least once every 4 months for ongoing controlled substance therapy
• New York (I-STOP): Must check before prescribing Schedule II–IV
• Texas: Must check before prescribing any controlled substance, every time (or have a documented exception)
• Florida, Pennsylvania, Illinois: Similar mandatory check requirements

PMPs are state-specific — if you’re licensed in multiple states, you need to register for each state’s system. Some states participate in interstate data sharing (PMP InterConnect), but you still need local registration.

E-Prescribing Requirements

Many states require electronic prescribing for controlled substances (EPCS):

• New York: Mandatory e-prescribing for controlled substances since 2016 (no paper scripts)
• California, Illinois: Strongly encouraged (some exceptions for technical failures)

You need:

• EPCS-certified software (two-factor authentication required)
• Identity proofing (in-person verification or equivalent for DEA EPCS registration)

Most telehealth platforms provide integrated e-prescribing, but confirm it’s EPCS-certified if you’re prescribing controlled substances.

Licensure: You Must Be Licensed Where the Patient Is

This trips up new telehealth providers constantly.

Rule: You must hold an active, unrestricted medical or nursing license in the state where the patient is physically located at the time of the visit.

If you’re seeing patients across multiple states, you need licenses in each state. No exceptions (except for narrow federal exemptions like VA providers or disaster response).

Interstate Medical Licensure Compact (IMLC):

• Expedites licensing for physicians across member states
• Among priority states: Texas, Pennsylvania, Illinois are members (California, New York, Florida are not)
• Still requires full state licensure — the compact just streamlines the application process

For PMHNPs: Some states participate in the APRN Compact (multistate NP license), but scope-of-practice rules are NOT harmonized — you still must follow each state’s collaboration requirements even with a compact license.

DEA Registration

To prescribe controlled substances, you need:

• Separate DEA registration in each state where you’re prescribing (state-specific DEA numbers)
• Or use your primary DEA number if prescribing telehealth-only (depends on state — some require a state-specific registration even for telehealth practice)

Check your state’s requirements — some allow using your primary DEA, others require registration at a physical practice location in-state (which can be complicated for pure telehealth providers).

The Provider Shortage Reality: Why This Matters

Let’s zoom out for a moment and look at why telehealth prescribing rules matter so much.

The United States has a massive psychiatric provider shortage:

• 122 million Americans live in mental health professional shortage areas (HPSAs)
• 6,500+ psychiatrists needed nationally to eliminate shortage areas
• Psychiatrist-to-population ratios by state:
• Texas: 1 psychiatrist per ~8,500 residents (worst in priority states) — 614 more psychiatrists needed
• Florida: 1 per ~9,000 residents — 500+ more needed
• California: 1 per ~5,300 residents — but still 11+ million in shortage areas
• Pennsylvania: 1 per ~4,600 residents — 99 more needed in rural areas
• Illinois: 1 per ~5,800 residents — 291 more providers needed
• New York: 1 per ~2,900 residents statewide (but concentrated in NYC — upstate severely underserved)

PMHNPs help fill the gap — but only if state laws let them practice to full scope:

• States that grant NP independence see faster growth in mental health access
• Restrictive states (Texas, Florida with psych NP restrictions) create artificial bottlenecks by limiting NP prescribing or requiring physician collaboration in already-underserved markets

Telehealth is the force multiplier:

• Allows providers in well-staffed urban areas to serve rural patients
• Enables retired or semi-retired psychiatrists to practice part-time from anywhere
• Lets new grads build practices without expensive brick-and-mortar overhead
• Provides access to specialized care (ADHD, OCD, eating disorders) in markets too small to support in-person specialists

The economic opportunity: High demand + limited supply = strong earning potential for psychiatric prescribers who embrace telehealth. But you have to navigate the regulatory maze correctly.

Practical Takeaways: What to Do Monday Morning

If you’re a psychiatrist:

1. Verify your licenses are current in every state where you see patients
2. Get DEA registrations for each state you’re prescribing controlled substances in
3. Register for PMPs in all your practice states (do it now — some take weeks to process)
4. Confirm your malpractice insurance covers telehealth practice in all your licensed states
5. Set up EPCS e-prescribing if you haven’t already (required in many states)
6. Stay updated on DEA rule changes — subscribe to professional association newsletters or set Google Alerts for ‘DEA telehealth prescribing’

If you’re a PMHNP:

1. Know your state’s scope-of-practice laws — can you prescribe independently or do you need a collaborator?
2. If you need collaboration: Secure a collaborative agreement BEFORE you start seeing patients (some states require board approval of the agreement, which takes time)
3. Understand your prescribing limits — can you prescribe Schedule II? Are there supply limits or notification requirements?
4. If practicing across state lines: You need separate collaborative agreements in each restricted/reduced-practice state (and they may have different requirements)
5. Track your hours if you’re in a transition-to-FPA state (New York, Illinois, California) — document everything for your independence application
6. Consider focusing on FPA states if you want to avoid collaboration hassles — but weigh that against market opportunity

For everyone:

1. Document thoroughly — treat telehealth notes with the same rigor as in-person visits
2. Get patient consent for telehealth (both general consent and controlled substance-specific if required)
3. Verify patient location at every visit (both for licensure compliance and emergency response)
4. Check PMPs religiously before prescribing controlled substances (set a reminder — it’s easy to forget and it’s a compliance time bomb)
5. Keep up with state law changes — subscribe to your state medical/nursing board newsletters, join professional associations, check CCHP’s 50-state database periodically

The Path Forward: Join Klarity Health

Here’s the honest truth about building a telehealth psychiatry practice in 2026:

You can absolutely do it independently. Hire an SEO agency, run Google Ads, optimize your Psychology Today listing, build a website, implement HIPAA-compliant telehealth software, credential with insurers, hire billing staff… and in 12–24 months, if you do everything right and have $20,000–$50,000 to invest, you might have a thriving practice.

Or you can join a platform that’s already done all of that.

Klarity Health provides:

• Pre-qualified psychiatric patients matched to your specialty and schedule
• No upfront marketing investment — pay only per appointment
• Built-in telehealth infrastructure (HIPAA-compliant, EPCS-enabled)
• Support for both insurance and cash-pay models
• Compliance support for multi-state licensing and collaborative agreements (if you’re an NP)
• Predictable economics — no gambling on marketing channels or seasonal patient flow

Who Klarity works best for:

• Psychiatrists and PMHNPs launching or expanding telehealth practices
• Providers looking to add flexible hours without overhead
• Clinicians expanding to new states (test markets without big upfront investment)
• Anyone who wants to focus on patient care instead of marketing and operations

The value proposition is simple: Would you rather spend your time optimizing Google Ads campaigns and negotiating with billing companies, or seeing patients and getting paid for it?

If you’re a qualified psychiatric prescriber (MD, DO, or PMHNP with appropriate licensure and scope), Klarity gives you immediate access to patients who need your help — without the risk and complexity of DIY practice building.

Ready to explore how Klarity can grow your practice?

Visit [Klarity’s provider portal] to learn more about joining the network, or schedule a call with the provider relations team to discuss how the platform fits your practice goals and state licensing.

The regulatory complexity around telepsychiatry prescribing isn’t going away — but it doesn’t have to slow you down. Whether you’re navigating NP scope-of-practice restrictions in Texas, building a cash-pay practice in California, or expanding to serve underserved markets in rural Pennsylvania, understanding the rules is step one.

Step two is choosing a practice model that lets you focus on what you do best: helping patients get the psychiatric care they need, wherever they are.

Frequently Asked Questions

Can psychiatrists prescribe controlled substances via telehealth in 2026?

Yes. Under current federal DEA waivers (extended through December 31, 2025), psychiatrists can prescribe Schedule II–V controlled substances — including stimulants, benzodiazepines, and buprenorphine — to new patients via telehealth without an initial in-person exam. This applies nationwide. However, the DEA is expected to finalize permanent rules by late 2024 that may impose some requirements (like periodic in-person visits or initial prescription limits), so stay alert for updates. Additionally, check your state’s laws: most states defer to federal rules, but some (like Texas) prohibit teleprescribing controlled substances for chronic pain (psychiatric treatment is exempt).

Can PMHNPs prescribe independently, or do they need a collaborating physician?

It depends entirely on the state. About 34 states grant Full Practice Authority (FPA) to experienced nurse practitioners, meaning PMHNPs can practice and prescribe independently with no physician oversight. Examples include Washington, Colorado, Arizona, and recently Massachusetts and Indiana. Some states like New York, Illinois, and California require an initial period of physician collaboration (2–4 years) before gr

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship